Prosthesis Mismatch in Supra and Intra Annular valves

The self-expandable valve was associated to lower prosthesis-patient mismatch (PPM) compared against the balloon expandable valve regardless annular area, according to this study soon to be published in J Am Coll Cardiol Intv. This difference was basically driven by patients with larger body surface area (>1.83m²).

Mismatch protésico en válvulas supra anulares y en válvulas intra anulares

Prosthesis mismatch has been associated to increased mortality after transcatheter aortic valve replacement (TAVR) and also after surgical valve replacement (SAVR).

Until recently there were no precise data on PPM frequency, let alone a comparison between supra-annular (self-expandable) and intra-annular (balloon expandable) valves. 

For this analysis, researchers included 757 patients between 2007 and 2017 treated with a self-expandable valve (CoreValve, Evolut R) and a balloon expandable valve (SAPIEN THV/XT/3).


Read also: Discordance Between FFR and iFR. Which Measurement Is More Important?


The mismatch was classified −according to discharge effective orifice area indexed to body surface area−  into severe (<0.65 cm²/m²) or moderate (0.65 to 0.85 cm²/m²) for the general population and into severe (<0.60 cm²/m²) or moderate (0.60 to 0.90 cm²/m²) for the obese population (body mass index ≥30kg/m²).

Propensity score was used to compare both populations, with 224 pairs of patients with similar baseline characteristics.

At discharge, the self-expandable prosthesis presented a much lower mismatch incidence compared against the balloon expandable valve (mismatch 33.5% vs. 46.9%, p=0.004; severe mismatch 6.7% vs. 15.6%, p=0.003). This difference in the general population was far more marked in the obese population. When considering only the non-obese population, the difference is no longer significant, which is why the general population results are tainted at the expense of the obese. 

At least at one year, the mismatch had no impact in cardiovascular mortality, or functional class.

Conclusion

The self-expandable valve was associated to lower mismatch rate vs. the balloon expandable valve regardless annulus area. This difference was basically driven by the group of larger patients with greater body surface (body mass >1.83 m²).

Original Title: Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement With Supra-Annular and Intra-Annular Prostheses.

Reference: Taishi Okuno et al. J Am Coll Cardiol Intv 2019, article in press.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....